IVC filter claims: what to check

Who can ask about a filter claim?

If you think an IVC filter harmed you, ask for a device and injury check. Bring the implant and care records you have. A filter in your body does not by itself prove a legal claim.

An IVC filter is placed in a large vein to catch clots before they travel to the lungs. The FDA says filters can be used when blood thinners cannot be used or have not worked. The reason for your filter and its present risks need a clinician's review.

The Bard order describes claims about filter design and warnings and notes that the company disputed them. Those disputes were not a finding that every implanted device caused harm. Ask the lawyer how the exact model, care findings and applicable law fit your situation.

Start with the name on an implant card or procedure record. If you do not know it, say so and ask how to obtain the record. Do not guess a brand from a picture online or assume that all filters fall within the same lawsuit.

How much money could I get?

There is no verified payment estimate for your filter claim here. A past payment to someone else is not your award. Ask how the evidence, legal issues and any agreement affect your own case.

The Bard order mentions some settled cases and others that still needed proceedings elsewhere. It does not publish a universal amount payable to everyone with an IVC filter. It also does not supply a payment schedule for all Cook devices or other brands.

For a legal conversation, prepare bills and dates of visits, scans and later procedures. Make a note of changes in daily tasks or work that you want checked. Ask which losses the relevant law permits and what proof is needed instead of selecting an online payout range.

If you already have an offer or agreement, ask who it binds and what rights it releases. Ask how fees and case expenses affect the amount you would receive. Ask the lawyer to explain the actual terms before you accept an offer.

What deadline applies to my claim?

A lawyer must check the claim and time limit that apply to you. The implant date alone cannot settle that question here. An old court schedule is not a national filing deadline.

The general court time-limit guidance says different claims can have different limits under applicable law. Ask a lawyer to consider the places and dates involved in your implant, injury and later care. This page does not calculate a filing date from those facts.

Prepare the dates you remember and mark uncertain dates as uncertain. Note when a clinician first told you about a possible filter problem and whether you already filed a claim. Keep any court papers or agreements so the lawyer can check their effect.

Do not assume that being part of a shared court proceeding pauses every time limit. Nor should you treat the date of a recall as the start or end of your deadline. Ask which specific law or order applies before relying on a date from a general page.

What does the filter evidence show?

One prospective study followed people who received filters at 54 US sites. It reported both benefits and complications. It was not a randomized comparison or proof that every filter model is safe for every patient over a lifetime.

Matthew S. Johnson and coauthors reported 1429 people who consented and 1421 who had filters placed. The study met its stated safety and effectiveness goals. It also reported adverse events, including a death during attempted removal. Those findings need their clinical context rather than a simple safe-or-defective label.

The original abstract shows varied follow-up and says many filters were removed. There was no random assignment to a filter or no-filter group. Those limits matter when applying a group result to your own device.

The FDA separately reviewed laser-assisted removal in 265 patients at seven sites. It reported 96% technical success and 3% significant device-related complications. That study concerns a selected removal procedure, not the chance that your implanted filter will fail.

A newer FDA record covers five Option ELITE delivery-system lots after reports of resistance while advancing a dilator inside a sheath. It records a device-specific action, not a recall of all implanted filters. Ask the clinician whether a notice matches your device and procedure.

Common questions

The proposed answers below separate medical care from a legal check. They cover records, fees, device notices and time limits. They cannot diagnose a complication or decide if a firm will take your claim.

How IVC Filters Fracture, Migrate, and Cause Catastrophic Injury

Inferior vena cava (IVC) filters are small metal devices implanted into the large vein returning blood to the heart, designed to trap blood clots and prevent pulmonary embolism. Retrievable IVC filters — marketed as temporary — became dominant in the early 2000s, but retrieval rates remained dismally low (estimated 8–40%). The core defect: filter struts fracture under the constant pulsatile stress of blood flow, sending metal fragments migrating through the bloodstream toward the heart, lungs, and surrounding organs. Manufacturers including C.R. Bard and Cook Medical knew of these failure modes years before federal regulators acted, yet continued selling defective devices to hundreds of thousands of patients annually.

Strut Fracture from Metal Fatigue

IVC filter struts — the thin metallic arms that anchor the device to the vein wall and trap clots — are subjected to continuous cyclic mechanical stress from heartbeat-driven blood pulsation. Over months or years of implantation, this cyclic loading causes metal fatigue fractures. In Bard Recovery and G2 filters, internal testing revealed fracture rates far exceeding those of competitors. Once a strut fractures, the broken fragment travels freely through the venous system. Bard's own pre-launch testing showed the Recovery filter had a fatigue profile that predicted fracture, yet the product was never pulled from market.

Filter Migration to Heart or Pulmonary Arteries

An intact or partially fractured filter can tilt and then migrate cephalad — upward through the inferior vena cava toward the heart. Migrated filters and fractured struts have been documented lodging in the right ventricle, right atrium, pulmonary arteries, and coronary vessels. Cardiac migration causes arrhythmias, cardiac tamponade (blood filling the pericardial sac), and death. Pulmonary arterial lodgment causes infarction. Because the vena cava carries all venous return from the lower body, any device that migrates has an unobstructed path to the heart. The FDA's MAUDE database contains hundreds of reports of IVC filter fragments recovered from cardiac structures.

Caval Perforation and Organ Penetration

Filter struts are designed to contact — but not penetrate — the vena cava wall. In defective designs, particularly the Cook Celect and Bard G2, strut tips erode through the vessel wall over time, perforating adjacent structures including the aorta, duodenum, ureter, lumbar vertebrae, and psoas muscle. Caval perforation is often asymptomatic until a strut reaches a pain-sensitive organ or causes bleeding. Post-market studies on Cook Celect filters showed caval perforation rates exceeding 40% at long-term follow-up — a rate never disclosed to implanting physicians or patients. Surgical retrieval of a perforating filter often requires open surgery with substantial morbidity.

Filter Tilt and Incomplete Thrombus Capture

Retrievable filters depend on symmetric deployment to efficiently capture blood clots. Filter tilt — where the device sits asymmetrically in the vena cava — reduces the effective filtration area, allowing clots to pass around the tilted device and reach the pulmonary circulation, causing the very pulmonary embolism the filter was meant to prevent. Tilt also accelerates strut stress concentration at anchor points, increasing fracture risk. Moreover, a tilted filter is dramatically more difficult or impossible to retrieve percutaneously, trapping patients with a permanently implanted defective device. The same design flaws that cause tilt — oversized strut angles relative to anatomical vena cava diameter variation — were identified in internal engineering documents years before field failures accumulated.

• Duration of Implant: Fracture and perforation risk increase substantially with time; patients implanted for more than 30 days face compounding failure probability, yet retrieval rates remain below 40% nationally due to inadequate physician follow-up protocols and patient tracking systems
• Retrievable Design Used Permanently: Retrievable filters were cleared by FDA under 510(k) as temporary devices but implanted permanently in the majority of patients — exposing them to long-term failure risks that retrievable filter designs were never validated to withstand
• Strut Design Defects in Bard Recovery/G2: Internal Bard testing documents produced in MDL 2641 discovery revealed the Recovery filter exhibited fatigue fracture at clinically relevant stress levels prior to commercial launch; the G2 replacement retained the same core strut geometry and exhibited similar failure rates
• Absence of Physician Retrieval Follow-Up: No industry-wide registry or mandatory follow-up protocol existed to track implanted retrievable filters; patients with retrievable filters left in place had no systematic mechanism to be recalled for removal, leaving fracture risk undetected until catastrophic failure

Cardiac Tamponade and Pericardial Injury from IVC Filter Migration

Life-threatening compression of the heart caused by fluid accumulation in the pericardial sac, precipitated by a migrated IVC filter strut penetrating the pericardium or myocardium. The impalement restricts cardiac filling, reduces cardiac output, and can cause hemodynamic collapse requiring emergency intervention.

• Severe chest pain radiating to back or left arm
• Beck's triad: hypotension, distended neck veins, muffled heart sounds
• Tachycardia and dyspnea
• Syncope or loss of consciousness
• Cardiac arrest
• Bard G2 or Recovery filter with known strut fracture
• Delayed diagnosis of initial filter fracture
• Filter placed suprarenally or near renal veins (proximity to heart)
• Failure of physician to recommend serial imaging after implantation
• Emergency pericardiocentesis (needle drainage of pericardial fluid)
• Emergency cardiothoracic surgery for strut removal
• Open cardiac surgery with bypass if strut embedded in myocardium
• Prolonged ICU admission and cardiac monitoring
• Anticoagulation and ongoing cardiological follow-up

Who Received IVC Filters: Patient Populations and Exposure Risk

Post-Surgical Patients with Temporary PE Risk

• Uses ivc filter products or devices as described
• Seeks medical evaluation for related symptoms or injuries
• Consults healthcare provider for ongoing care
• Documents exposure history and medical records

Trauma Patients

• Uses ivc filter products or devices as described
• Seeks medical evaluation for related symptoms or injuries
• Consults healthcare provider for ongoing care
• Documents exposure history and medical records

Cancer Patients

• Uses ivc filter products or devices as described
• Seeks medical evaluation for related symptoms or injuries
• Consults healthcare provider for ongoing care
• Documents exposure history and medical records

Elderly Patients with Cardiovascular Comorbidity

• Uses ivc filter products or devices as described
• Seeks medical evaluation for related symptoms or injuries
• Consults healthcare provider for ongoing care
• Documents exposure history and medical records